Table 3.

Crude Associations Between Clinical and Psychosocial Factors and AET Adherence Ratio

Factor	β-coefficient	Standard Error	p-value1
Clinical
Comorbid HIV Infection	−0.03	0.03	0.31
Age	0.01	0.01	0.29
BC Stage (I/II vs III)	−0.01	0.03	0.64
HER2 Status (Positive vs Negative)	0.01	0.03	0.91
Tamoxifen Prescription	0.02	0.03	0.61
Number of Other Medications Used (Non-ART)	−0.01	0.01	0.42
Social
Married/Domestic Partner	0.02	0.02	0.28
Tobacco Smoking	0.06	0.05	0.21
Alcohol Use	0.02	0.02	0.57
Wealth Percentile	0.02	0.01	0.06
Psychosocial
SSSS - Partner	0.001	0.01	0.69
SSSS - Women in Your Family	0.002	0.01	0.63
SSSS - Friends	0.01	0.004	0.09
SSSS - HCP	0.002	0.01	0.70
HELT-LL - Total Score	0.003	0.003	0.32
BMQ - AET Concerns	−0.01	0.003	0.001
BMQ - AET Necessity	−0.003	0.004	0.40
BMQ - General Overuse	−0.01	0.003	0.11
BMQ - General Harms	−0.01	0.004	0.16
CASE-Cancer - Total Score	0.003	0.003	0.45
CES-D Score	−0.002	0.001	0.12
GAD-7 Score	−0.01	0.002	0.04
PSS Score	−0.002	0.002	0.29
AET-Related Side Effects
Cognitive	−0.001	0.001	0.91
Musculoskeletal	−0.001	0.001	0.88
Vasomotor	−0.01	0.003	0.07
Gastrointestinal	−0.02	0.01	0.09
Dyspareunia	0.001	0.007	0.87
Weight Control	−0.001	0.006	0.84
Gynecologic	−0.001	0.001	0.91
Urinary Incontinence	−0.001	0.001	0.90
Pain/Fatigue	−0.001	0.002	0.57

^1:P-value of the relevant factor in a hierarchical linear models of adherence ratio with study timepoint as the only other covariate,

Abbreviations: AET – adjuvant endocrine therapy; ART – antiretroviral therapy; BC – breast cancer; BMQ – Beliefs About Medication Questionnaire; CASE-Cancer – Communication and Attitudinal Self-Efficacy scale; CES-D – Center for Epidemiological Studies Depression Scale; GAD-7 – Generalized Anxiety Disorder 7-Item Scale; HELT-LL – Health Literacy Test for Limited Literacy populations; HER2 -human epidermal growth factor receptor 2; PSS – Perceived Stress Scale; SSSS – Sources of Social Support Scale